Home Cart 0 Sign in  
X

[ CAS No. 16554-45-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 16554-45-3
Chemical Structure| 16554-45-3
Chemical Structure| 16554-45-3
Structure of 16554-45-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 16554-45-3 ]

Related Doc. of [ 16554-45-3 ]

Alternatived Products of [ 16554-45-3 ]

Product Details of [ 16554-45-3 ]

CAS No. :16554-45-3 MDL No. :MFCD01930197
Formula : C7H8N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :NDKWDGCTUOOAPF-UHFFFAOYSA-N
M.W : 168.15 Pubchem ID :85491
Synonyms :

Calculated chemistry of [ 16554-45-3 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.16
TPSA : 81.07 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.48
Log Po/w (XLOGP3) : 0.73
Log Po/w (WLOGP) : 1.19
Log Po/w (MLOGP) : 0.05
Log Po/w (SILICOS-IT) : -1.04
Consensus Log Po/w : 0.48

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.58
Solubility : 4.42 mg/ml ; 0.0263 mol/l
Class : Very soluble
Log S (Ali) : -2.01
Solubility : 1.64 mg/ml ; 0.00975 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.54
Solubility : 4.85 mg/ml ; 0.0288 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.2

Safety of [ 16554-45-3 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501 UN#:2811
Hazard Statements:H301-H311-H331 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 16554-45-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 16554-45-3 ]
  • Downstream synthetic route of [ 16554-45-3 ]

[ 16554-45-3 ] Synthesis Path-Upstream   1~30

  • 1
  • [ 16554-45-3 ]
  • [ 27080-53-1 ]
Reference: [1] European Journal of Medicinal Chemistry, 2013, vol. 68, p. 222 - 232
  • 2
  • [ 16554-45-3 ]
  • [ 102-51-2 ]
Reference: [1] Patent: JP5670893, 2015, B2, . Location in patent: Paragraph 0245; 0246
  • 3
  • [ 555-03-3 ]
  • [ 16554-45-3 ]
  • [ 96-96-8 ]
Reference: [1] Patent: US5466871, 1995, A,
  • 4
  • [ 555-03-3 ]
  • [ 16554-45-3 ]
  • [ 97-52-9 ]
  • [ 96-96-8 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 15, p. 4878 - 4888
[2] Journal of Organic Chemistry, 1996, vol. 61, # 2, p. 442 - 443
[3] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 11, p. 1437 - 1444
  • 5
  • [ 16554-45-3 ]
  • [ 2687-25-4 ]
Reference: [1] Patent: JP5670893, 2015, B2, . Location in patent: Paragraph 0222; 0234; 0235
  • 6
  • [ 16554-45-3 ]
  • [ 67853-37-6 ]
YieldReaction ConditionsOperation in experiment
50%
Stage #1: With hydrogen bromide; sodium nitrite In water at 0℃; for 0.666667 h;
Stage #2: With copper(I) bromide In water at 0 - 60℃; for 2 h; Heating / reflux
A solution of sodium nitrite (1.48 mol) in water (250 mL) was added to a cold (0-5° C.) solution of the nitroaniline (1.08 mol) in hydrobromic acid (4.87 mol) (prepared by heating the reaction mixture at 90° C. for 2 h).
The reaction mixture was maintained for 40 min and was filtered.
The filtrate was added dropwise to a cold (0-5° C.) solution of copper (I) bromide (1.81 mol) in hydrobromic acid (640 mL) and the reaction mixture was maintained for 30 min.
The reaction mixture was warmed to 60° C. and was maintained for 30 min.
The reaction mixture was warmed to reflux and was maintained for 1 h.
The reaction mixture was diluted with water (2 L) and was extracted with dichloromethane (3*1 L).
The combined organic layers were washed with 10percent sodium hydroxide (1.0 L), water (2.0 L), 10percent hydrochloric acid (1.6 L) and water (2.0 L), dried (magnesium sulfate) and concentrated.
The residue was recrystallized from ethanol to provide the bromide in 50percent yield as a yellow solid.
Reference: [1] Patent: US2007/78147, 2007, A1, . Location in patent: Page/Page column 67
[2] Bulletin of the Chemical Society of Japan, 1978, vol. 51, p. 2437 - 2438
[3] Journal of Medicinal Chemistry, 2006, vol. 49, # 17, p. 5352 - 5362
  • 7
  • [ 16554-45-3 ]
  • [ 603-84-9 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1930, vol. <2> 127, p. 20,22
  • 8
  • [ 116496-81-2 ]
  • [ 15969-08-1 ]
  • [ 16554-45-3 ]
Reference: [1] Journal of the Chemical Society, 1926, p. 1319
  • 9
  • [ 16554-45-3 ]
  • [ 3970-39-6 ]
YieldReaction ConditionsOperation in experiment
16.5 g
Stage #1: With hydrogenchloride; sodium nitrite In water at 0℃; for 0.25 h;
Stage #2: With hydrogenchloride; copper(l) chloride In water at 0 - 50℃; for 0.5 h;
INTERMEDIATE: (5-Methoxy-3-methyl-quinoxalin-2-yl)-hydrazine (lie). 2-Methoxy-6-nitro- phenylamine (25.0 g) was dissolved in 37percent aq HC1, and the mixture ws cooled on an ice/water bath. A solution of NaN02 (11.8 g) in water (3 mL) was added, and the resulting mixture was stirred at 0 °C for 15 min. The reaction mixture was added to a solution of cuprous monochloride (14.7 g) in 37percent aq HC1 (10 mL) under stirring at 45-50 °C. The resulting mixture was stirred at 50 °C for 15 min, cooled at 5 °C for 15 min. The solid was filtered off and dried to give 2-chloro-l-methoxy-3- nitrobenzene (16.5 g). A mixture of 16 g of this material, racemic alanine (17 g), and K2CO3 (12 g) was heated in DMSO (180 mL) at 100 °C for 24h. The volatiles were removed using a freeze dryer. The residue was acidified with 2M aq HC1 (50 mL) and extracted into EtOAc. The organic extract was extracted with 2M aq Na2C03 and water. The combined aq extracts were acidified with 2M aq HC1 and extracted with EtOAc. The organic layer was washed with brine, dried over MgSO i, filtered, and concentrated in vacuo to afford 2-(2-methoxy-6-nitro-phenylamino)-propionic acid. This material was dissolved in ethanol (600 mL) and 96percent> sulphuric acid (6 mL) was added. The mixture was heated at 80 °C overnight. The volatiles were removed in vacuo and the residue was dissolved in EtOAc and washed with 2M aq Na2C03. The organic layer was dried over MgSO i, filtered, and concentrated in vacuo to afford 2-(2-methoxy-6-nitro-phenylamino)-propionic acid ethyl ester (8.0 g). This material was dissolved in ethanol (300 mL) and 5percent palladium on carbon was added. The mixture was treated with 3 bars of hydrogen pressure on a Parr shaker for 3h. The catalyst was filtered off, and the filtrate was concentrated in vacuo. The residue was purified by chromatography on silica (eluent: heptanes→ EtOAc) to afford 5-methoxy-3-methyl-3,4-dihydro- lH-quinoxalin-2-one (3.0 g). This material was dissolved in ethanol (300 mL) and treated with 30percent aq hydrogen peroxide at 80 °C overnight. Most of the volatiles were removed in vacuo. The residue was suspended in ethanol (10 mL) and cooled on an ice/water bath before the solid was filtered off, washed with ice-cold ethanol, and dried to afford 5-methoxy-3-methyl-lH-quinoxalin-2-one (2.2 g). This material was dissolved in phosphoryl chloride (24 mL) and heated at 130 °C for 2h. The volatiles were removed in vacuo. The residue was partitioned between chloroform and ice + 2M aq NaOH. The organic layer was dried over MgSO i, filtered, and concentrated in vacuo to afford 2- chloro-5-methoxy-3-methyl-quinoxaline (2.5 g). This material was dissolved in ethanol (22 mL), hydrazine hydrate (2.9 mL) was added, and the mixture was refluxed for 2h. The volatiles were removed in vacuo, and water was added. The solid was filtered off, washed with water and heptanes and dried to afford lie (1.70 g) sufficiently pure for the next step.
Reference: [1] Chemistry - A European Journal, 2017, vol. 23, # 42, p. 9996 - 10000
[2] Journal fuer Praktische Chemie (Leipzig), 1930, vol. <2> 127, p. 20,22
[3] Patent: WO2005/68433, 2005, A1, . Location in patent: Page/Page column 38
[4] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 17, p. 5161 - 5164
[5] Patent: WO2013/34755, 2013, A1, . Location in patent: Page/Page column 18
  • 10
  • [ 16554-45-3 ]
  • [ 37466-89-0 ]
YieldReaction ConditionsOperation in experiment
94% With palladium 10% on activated carbon; hydrogen In methanol at 20℃; for 2 h; At room temperature, to a solution of 2-methoxy-6-nitroaniline (4.75 g, 28.25 minol) in methanol (150 mL) was added Pd/C (10percent, 500 mg) under nitrogen atmosphere. The reaction flask was vacuumed and flushed with hydrogen. The reactionminxture was hydrogenated for 2 h at room temperature under H2 atmosphere using a hydrogen balloon. When the reaction was done, the reactionminxture was filtered through a Celite pad and the filtrate was concentrated under reduced pressure to yield 3-methoxybenzene-1,2-diamine as dark red oil (3.66 g, 94percent). MS: m/z = 139.1 [M+Hj.
77% With palladium 10% on activated carbon; hydrogen In ethanol at 20℃; for 2 h; The mixture of 2-methoxy-6-nitroaniline (1, 300mg, 1.78mmol) and 10percent Pd/C (60mg) in ethanol (15mL) was stirred under hydrogen atmosphere at room temperature and atmospheric pressure for 2h. The solid was removed by filtration and the filtrate was concentrated. The residue was purified by column chromatography on silicagel with petroleum ether–AcOEt (v/v=3/1). The title compound 2 (190mg, 77percent yield) was obtained as off-white powder. M.p. 77–78°C; 1H NMR (CDCl3, 300MHz, δ ppm): 6.68 (1H, t, J=7.8Hz), 6.41 (2H, td, J1=7.5Hz, J2=1.2Hz), 3.84 (3H, s), 3.31 (4H, br s); HRMS (ESI): m/z, calcd. For C7H11N2O [M+H]+ 138.0866, found 138.0870.
Reference: [1] Patent: WO2017/106607, 2017, A1, . Location in patent: Paragraph 00459
[2] Journal of Asian Natural Products Research, 2011, vol. 13, # 4, p. 330 - 340
[3] European Journal of Medicinal Chemistry, 2013, vol. 68, p. 222 - 232
[4] Journal of the Chemical Society, 1954, p. 2977
[5] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3515 - 3527
[6] Patent: US2004/6119, 2004, A1, . Location in patent: Page/Page column 17
[7] Patent: EP508800, 1992, A1,
[8] Patent: US2007/10542, 2007, A1, . Location in patent: Page/Page column 72
[9] Patent: US2004/19058, 2004, A1,
[10] Patent: US6353010, 2002, B1, . Location in patent: Page column 9
[11] Journal of Medicinal Chemistry, 2011, vol. 54, # 20, p. 7105 - 7126
[12] Patent: WO2012/40040, 2012, A1, . Location in patent: Page/Page column 48
[13] Applied Organometallic Chemistry, 2014, vol. 28, # 6, p. 389 - 395
[14] Archives of Pharmacal Research, 2017, vol. 40, # 4, p. 469 - 479
[15] Journal of Medicinal Chemistry, 2017, vol. 60, # 14, p. 6289 - 6304
  • 11
  • [ 603-85-0 ]
  • [ 74-88-4 ]
  • [ 16554-45-3 ]
YieldReaction ConditionsOperation in experiment
91% With potassium carbonate In N,N-dimethyl-formamide for 14 h; Step 1: 2-methoxy-6~nitroaniline; A mixture of 2-amino-3-nitrophenol (1 1.66 g, 76 mmol) and K2C03 (12.55 g, 91 mmol) were stirred in DMF (100 ml) for 1 hour. Iodomethane (5.68 ml, 91 mmol) in DMF (lOmL) was added dropwise, and the mixture was stirred 14 hours. The reaction was diluted with H2 and extracted with EtOAc (2x). The organics were washed with brine, dried over Na2S04, filtered, concentrated to a dark solid. The crude solid was purified by crystallization from hexane to give the title compound as an orange solid (11 ,6g, 91percent). LCMS (ES+) m/z 169.0 (M+H)+.
90% With potassium carbonate In N,N-dimethyl-formamide at 20℃; To a mixture of 2-amino-3-nitrophenol (19.25 g) and K2CO3 (19 g) in DMF (100 mL) was added MeI (11 mL) at room temperature and the mixture was stirred over night and then poured into water.
The resulting precipitate was collected by filtration and the solid was washed with water to afford the desired product (19 g, 90percent).
1H NMR (300 MHz, CDCl3) δ ppm 3.92 (s, 1H), 6.43 (br s, 1H), 6.61 (dd, 1H, J=7.5, 9.0 Hz), 6.89 (dd, 1H, J=0.9, 7.5 Hz), 7.73 (dd, 1H, J=0.9, 9.0 Hz); LC-MS: m/e=169 [M+1]+
89% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 1.5 h; The mixture of 2-amino-3-nitrophenol (308mg, 2mmol) and K2CO3 (552mg, 4mmol) in DMF (5mL) were stirred at room temperature for 30min before addition of MeI (0.15mL, 2.5mmol). After stirred at room temperature for 1h, the reaction mixture was diluted with water (30mL) and extracted with ethyl ether (15mL×3). The combined organic layer was washed with water and brine and then dried over anhydrous MgSO4, filtered and concentrated to give the crude product, which was purified by column chromatography on silica gel with petroleum ether/AcOEt (v/v=12:1). The title compound (300mg, 89percent yield) was afforded as salmon pink powder. M.p. 68–69°C; 1H NMR (CDCl3, 300MHz, δ ppm): 7.73 (1H, d, J=9.3Hz), 6.88 (1H, d, J=7.8Hz), 6.60 (1H, t, J=7.5Hz), 6.42 (2H, br s), 3.92 (3H, s); HRMS (ESI): m/z, calcd. For C7H9N2O3 [M+H]+: 169.0608, found 169.0607.
89% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 16 h; 2-Methoxy-6-nitroaniline
To a solution of 2-amino-3-nitrophenol (35 g, 227 mmol) in DMF (400 ml_), K2C03(37.7 g, 273 mmol) and Mel (17.04 ml_, 273 mmol) were added at RT. The reaction mixture was stirred at RT for 16 h. Then it was poured into water. The resulting precipitate was collected by filtration and the solid was washed with water to give 35 g (89percent) of the title compound. LC-MS m/z 168.9 (M+H)+, 1.71 (ret. time).
89% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 16 h; Intermediate 4 2-Methoxy-6-nitroaniline To a solution of 2-amino-3-nitrophenol (35 g, 227 mmol) in Ν,Ν-dimethylformamide (DMF) (400 mL), K2C03 (37.7 g, 273 mmol) and iodomethane (17.04 mL, 273 mmol) were added at ambient temperature. The reaction mixture was stirred at ambient temperature for 16 h. Then it was poured into water. The resulting precipitate was collected by filtration and the solid was washed with water to give 35 g (89percent) of the title compound. LC-MS m/z 168.9 (M+H)+, 1 .71 min (ret. time).
87% With potassium hydroxide In N,N-dimethyl-formamide at 20℃; c) 2-methoxy-6-nitro-phenylamine: 85percent potassium hydroxide solution (11.7 g, 0.179 mol) is added to a solution of 25 g (0.162 mol) 2-amino-3-nitro-phenol in 200 mL DMF. Then 11.1 mL (0.178 mol) iodomethane are added dropwise and the mixture is stirred overnight at ambient temperature. The reaction mixture is poured onto ice and stirred for one hour. The precipitated product is filtered off, washed with water and dried. Yield: 23.8 g (87percent); mass spectroscopy: [M+H]+=169.
87% With potassium hydroxide In DMF (N,N-dimethyl-formamide) at 20℃; 85percent potassium hydroxide solution (11.7 g, 0.179 mol) is added to a solution of 25 g (0.162 mol) 2-amino-3-nitro-phenol in 200 mL DMF. Then 11.1 mL (0.178 mol) iodomethane are added dropwise and the mixture is stirred overnight at ambient temperature. The reaction mixture is poured onto ice and stirred for one hour. The precipitated product is filtered off, washed with water and dried. Yield: 23.8 g (87percent); mass spectroscopy: [M+H]+=169
87% With potassium hydroxide In water; N,N-dimethyl-formamide at 0 - 20℃; c)
2-methoxy-6-nitro-phenylamine
85percent potassium hydroxide solution (11.7 g, 0.179 mol) is added to a solution of 25 g (0.162 mol) 2-amino-3-nitro-phenol in 200 mL DMF. Then 11.1 mL (0.178 mol) iodomethane are added dropwise and the mixture is stirred overnight at ambient temperature.
The reaction mixture is poured onto ice and stirred for one hour.
The precipitated product is filtered off, washed with water and dried.
Yield: 23.8 g (87percent); mass spectroscopy: [M+H]+=169.
81%
Stage #1: With potassium carbonate In N,N-dimethyl-formamide for 0.0833333 h;
Stage #2: at 20℃; for 2 h;
To a solution of 2-amino-3-nitrophenol (2.55 g, 16.55 mmol) dissolved in N,Ndimethylformamide (35 mL) was added potassium carbonate (2.52 g, 18.20 mmol). The mixturewas stirred for 5 mm before iodomethane (1 .138 mL, 18.20 mmol) was added and the reactionallowed to stir at ambient temperature for 2 h. water75 mL) was added to quench the reactionand the precipitate product was collected by filtration, washed with water to afford the titlecompound 2-methoxy-6-nitroaniline (2.26 g, 81 percent). LC-MS m/z 168.9 (M+H), 0.74 mm (ret.time)
81% at 20℃; for 2 h; To a solution of 2-amino-3-nitrophenol (2.55 g, 16.55 mmol) dissolved in N,N- dimethylformamide (35 mL) was added potassium carbonate (2.52 g, 18.20 mmol). The mixture was stirred for 5 min before iodomethane (1.138 mL, 18.20 mmol) was added and the reaction allowed to stir at ambient temperature for 2 h. water75 mL) was added to quench the reaction and the precipitate product was collected by filtration, washed with water to afford the title compound 2-methoxy-6-nitroaniline (2.26 g, 81 percent). LC-MS m/z 168.9 (M+H)+, 0.74 min (ret. time)
76% With potassium carbonate In water; N,N-dimethyl-formamide Step 1.
2-Methoxy-6-nitrophenylamine.
To a solution of 2-amino-3-nitrophenol (5 g, 32.4 mmol) in DMF (165 ml) were sequentially added potassium carbonate (9.0 g, 65 mmol) and methyl iodide (2.2 ml, 35 mmol).
The mixture was heated at 50° C. overnight before it was cooled to room temperature, mixed with water (300 ml), and extracted with ethyl acetate (3*50 ml).
The extracts were combined, washed with water (150 ml), brine (80 ml), and dried (MgSO4).
Removal of the solvent under reduced pressure gave a dark orange solid that was triturated with 1:1 hexane/ether.
The solids were collected by filtration to give product 136 as orange needles (4.1 g, 76percent).
50% With caesium carbonate In tetrahydrofuran at 18 - 25℃; for 144 h; In the case of SM Ic an additional step needed to be carried out as shown below: 2-amino-3-nitro-6methoxybenzene:Into a 250ml round bottom flask was fed 2-amino-3-nitrophenol (2.04g, 13.24mmol) and 50ml anhydrous THF. Cesium carbonate (18.98g, 58.26mmol) was added into the solution followed by methyl iodide (2.07g, 14.56mmol). The mixture was stirred 6 days at room temperature. The resulting mixture was filtered and washed with DCM. The solvent was removed on a rotary evaporator. The crude material was purified by silica gel chromatography (gradient elution; EtOAc: Hexane 20percent) to afford title compound (l.lg, 50percent) M/Z 168.
29.4 g With tetra-(n-butyl)ammonium iodide; sodium hydroxide In tetrahydrofuran; water at 20℃; INTERMEDIATE (7-Bromo-5 -methoxy-3 -methyl-quinoxalin-2-yl)-hydrazine (Ilq). 2-Amino-3-nitrophenol (25 g) and NaOH (25.0 g) were dissolved in a mixture of THF (500 mL) and water (200 mL). TBAI (2.5 g) and methyl iodide (21.2 mL) were added. The mixture was stirred overnight at ambient temperature. Most of the THF was removed in vacuo. The residue was partitioned between water and EtOAc. The organic layer was washed with brine, dried over MgSO i, filtered, and concentrated in vacuo to afford 2-methoxy-6-nitro-phenyl amine (29.4 g). 22 g of this material and NaOAc (17.8 g) were mixed in acetic acid (300 mL) at ambient temperature. Bromine (6.9 mL) in acetic acid (5 mL) was added drop-wise over 15 min. The precipitated solid was filtered off, washed with water and heptanes, and dried to afford 4-bromo-2-methoxy-6-nitro-phenylamine (25.5 g). 2.47 g of this material dissolved in DCM (100 mL). DMAP (1.22 g) and Boc20 (2.62 g) were added, and the mixture was overnight at ambient temperature. The volatiles were removed in vacuo. The residue was purified by chromatography on silica gel (eluent: heptanes→ EtOAc). Fractions containing the desired material were pooled and most of the EtOAc was removed in vacuo. The residual solution was diluted with heptanes, and the resulting mixture was allowed to stand at ambient temperature overnight. The precipitated solid was filtered off and dried to afford (4-bromo- 2-methoxy-6-nitro-phenyl)-iminocarbonicacid-bis-(tert-butyl ester) (3.94 g). A larger portion of this material (25.6 g) prepared in a similar manner was dissolved in ethanol (700 mL). 5percent Platinum on charcoal (4.0 g) was added, and the mixture was treated with hydrogen gas (1 bar) for 45 min using a Parr shaker instrument. The catalyst was filtered off. The filtrate was concentrated in vacuo. The residual solid was suspended in heptanes, filtered, and dried to afford 6-amino-4-bromo-2-methoxy- phenyl)-iminocabonicacid-bis (fert-butyl ester) (22.0 g). This material was dissolved in DCM (250 mL) and treated with TFA (5 mL) overnight at ambient temperature. The volatiles were removed in vacuo. The residue was partitioned between EtOAc and 2M aq NaOH (until pH was 9). The organic layer was dried over MgSO i, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel (eluent: heptanes→ EtOAc) to afford the mono-deprotected material (ca 11 g). This material was dissolved in a mixture of DCM (100 mL) and TFA (50 mL) and stirred overnight at ambient temperature. The volatiles were removed in vacuo. The residue was partitioned between EtOAc and 2M NaOH (until pH 9). The organic layer was dried over MgSO i, filtered, and concentrated in vacuo to afford 5-bromo-3-methoxy-benzene-l,2-diamine (3.63 g). This material was dissolved in methanol (200 mL). 2-Oxo-propanoic acid methyl ester (2.0 g) was added, and the mixture was stirred overnight at ambient temperature. The precipitated 7-bromo-5-methoxy-3- methyl-lH-quinoxalin-2-one was filtered off. The filtrate was concentrated in vacuo. The residue was purified by chromatography on silica gel (eluent: heptanes→ EtOAc) to afford more 7-bromo- 5-methoxy-3-methyl-lH-quinoxalin-2-one as the first eluting isomer followed by 6-bromo-8- methoxy-3-methyl-lH-quinoxalin-2-one as the second eluting isomer. The two crops of 7-bromo-5- methoxy-3-methyl-lH-quinoxalin-2-one were mixed and washed with a little acetone to afford 7- bromo-5-methoxy-3 -methyl- lH-quinoxalin-2-one (1.7 g) sufficiently pure for the next step. The fractions containing the second eluting isomer were pooled and concentrated in vacuo; the residual solid was washed with a little acetone to afford 6-bromo-8-methoxy-3-methyl-lH-quinoxalin-2-one (0.61 g) sufficiently pure for the next step. The structure of the isomers were elucidated by identifying the nitrogen carrying a proton by 2D HSQC and comparing with the shift of the nitrogen having long range correlation to an aromatic proton in 2D HMBC. 7-Bromo-5- methoxy-3-methyl-lH-quinoxalin-2-one (1.7 g) was refluxed in phosphoryl chloride (23 mL) for 2h. The volatiles were removed in vacuo. The residue was partitioned between DCM and ice/water. The mixture was basified with 2M aq Na2C03. The organic layer was dried over MgSO i, filtered, and concentrated in vacuo to afford 7-bromo-2-chloro-5-methoxy-3-methyl-quinoxaline (0.61 g). This material was dissolved in ethanol (38 mL). Hydrazine hydrate (3 mL) was added and the mixture was refluxed for 2h. The volatiles were removed in vacuo. The residual solid was suspended in water, filtered off, washed with heptanes, and dried to afford Ilq (0.58 g) sufficiently pure for the next step.
29.4 g With tetra-(n-butyl)ammonium iodide; sodium hydroxide In tetrahydrofuran; water at 20℃; INTERMEDIATE 6-Bromo-8-methoxy-3-methyl-quinoxalin-2-yl)-hydrazine (Ilf). 2-Amino-3-nitrophenol (25 g) and NaOH (25.0 g) were dissolved in a mixture of THF (500 mL) and water (200 mL). TBAI (2.5 g) and methyl iodide (21.2 mL) were added. The mixture was stirred overnight at ambient temperature. Most of the THF was removed in vacuo. The residue was partitioned between water and EtOAc. The organic layer was washed with brine, dried over MgSO i, filtered, and concentrated in vacuo to afford 2-methoxy-6-nitro-phenyl amine (29.4 g). 22 g of this material and NaOAc (17.8 g) were mixed in acetic acid (300 mL) at ambient temperature. Bromine (6.9 mL) in acetic acid (5 mL) was added drop-wise over 15 min. The precipitated solid was filtered off, washed with water and heptanes, and dried to afford 4-bromo-2-methoxy-6-nitro- phenylamine (25.5 g). 2.47 g of this material dissolved in DCM (100 mL). DMAP (1.22 g) and B0C2O (2.62 g) were added, and the mixture was overnight at ambient temperature. The volatiles were removed in vacuo. The residue was purified by chromatography on silica gel (eluent: heptanes→ EtOAc). Fractions containing the desired material were pooled and most of the EtOAc was removed in vacuo. The residual solution was diluted with heptanes, and the resulting mixture was allowed to stand at ambient temperature overnight. The precipitated solid was filtered off and dried to afford (4-bromo-2-methoxy-6-nitro-phenyl)-iminocarbonicacid-bis-(tert-butyl ester) (3.94 g). A larger portion of this material (25.6 g) prepared in a similar manner was dissolved in ethanol (700 mL). 5percent Platinum on charcoal (4.0 g) was added, and the mixture was treated with hydrogen gas (1 bar) for 45 min using a Parr shaker instrument. The catalyst was filtered off. The filtrate was concentrated in vacuo. The residual solid was suspended in heptanes, filtered, and dried to afford 6-amino-4-bromo-2-methoxy-phenyl)-iminocabonicacid-bis (tert- butyl ester) (22.0 g). This material was dissolved in DCM (250 mL) and treated with TFA (5 mL) overnight at ambient temperature. The volatiles were removed in vacuo. The residue was partitioned between EtOAc and 2M aq NaOH (until pH was 9). The organic layer was dried over MgSO i, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel (eluent: heptanes→ EtOAc) to afford the mono-deprotected material (ca 11 g). This material was dissolved in a mixture of DCM (100 mL) and TFA (50 mL) and stirred overnight at ambient temperature. The volatiles were removed in vacuo. The residue was partitioned between EtOAc and 2M NaOH (until pH 9). The organic layer was dried over MgS04, filtered, and concentrated in vacuo to afford 5-bromo-3-methoxy-benzene-l,2-diamine (3.63 g). This material was dissolved in methanol (200 mL). 2-Oxo-propanoic acid methyl ester (2.0 g) was added, and the mixture was stirred overnight at ambient temperature. The precipitated 7-bromo-5-methoxy-3-methyl-lH- quinoxalin-2-one was filtered off. The filtrate was concentrated in vacuo. The residue was purified by chromatography on silica gel (eluent: heptanes→ EtOAc) to afford more 7-bromo-5-methoxy- 3-methyl-lH-quinoxalin-2-one as the first eluting isomer followed by 6-bromo-8-methoxy-3- methyl-lH-quinoxalin-2-one as the second eluting isomer. The two crops of 7-bromo-5-methoxy- 3-methyl-lH-quinoxalin-2-one were mixed and washed with a little acetone to afford 7-bromo-5- methoxy-3-methyl-lH-quinoxalin-2-one (1.7 g) sufficiently pure for the next step. The fractions containing the second eluting isomer were pooled and concentrated in vacuo; the residual solid was washed with a little acetone to afford 6-bromo-8-methoxy-3-methyl-lH-quinoxalin-2-one (0.61 g) sufficiently pure for the next step. The structure of the isomers were elucidated by identifying the nitrogen carrying a proton by 2D ^N-'H HSQC and comparing with the shift of the nitrogen having long range correlation to an aromatic proton in 2D ^N-'H HMBC. 6-bromo- 8-methoxy-3-methyl-lH-quinoxalin-2-one (1.7 g) was dissolved in phosphoryl chloride (23 mL) was refluxed for 2h. The volatiles were removed in vacuo. The residue was partitioned between DCM and a little ice. The biphasic mixture was basified with 2M aq Na2C03 and was filtered. The organic part of the filtrate was dried over MgSO i, filtered, and concentrated in vacuo to afford 7- bromo-3-chloro-5-methoxy-2-methyl-quinoxaline (1.1 g). This material was dissolved in ethanol (38 mL). Hydrazine hydrate (3 mL) was added, and the mixture was refluxed for 2h. The volatiles were removed in vacuo. The residue was suspended in water (50 mL). The solid was filtered off, washed with heptanes and dried to afford Ilf (1.6 g) sufficiently pure for the next step.
9.85 g With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 2 h; C)
2-Methoxy-6-nitroaniline
To a solution of 2-amino-3-nitrophenol (9.12 g) and potassium carbonate (13.6 g) in DMF (100 mL), iodomethane (4.44 mL) was added at room temperature, and the mixture was stirred at room temperature for 2 hours.
Water was added to the reaction mixture at room temperature.
The deposited solid was collected by filtration and washed with water and hexane to obtain the title compound (9.85 g).
1H NMR (300MHz, DMSO-d6) δ 3.88 (3H, s), 6.61 (1H, dd, J = 8.9, 7.7 Hz), 6.95-7.17 (3H, m), 7.59 (1H, dd, J = 8.9, 1.3 Hz).

Reference: [1] Patent: WO2012/40040, 2012, A1, . Location in patent: Page/Page column 47-48
[2] Journal of Medicinal Chemistry, 2006, vol. 49, # 17, p. 5352 - 5362
[3] Patent: US2012/88767, 2012, A1, . Location in patent: Page/Page column 16; 22
[4] Journal of Asian Natural Products Research, 2011, vol. 13, # 4, p. 330 - 340
[5] European Journal of Medicinal Chemistry, 2013, vol. 68, p. 222 - 232
[6] Patent: WO2015/92713, 2015, A1, . Location in patent: Page/Page column 69; 154; 155
[7] Journal of Medicinal Chemistry, 2016, vol. 59, # 8, p. 3991 - 4006
[8] Patent: WO2016/203400, 2016, A1, . Location in patent: Page/Page column 45; 46
[9] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3515 - 3527
[10] Patent: US2007/249595, 2007, A1, . Location in patent: Page/Page column 8-9
[11] Patent: US2006/63817, 2006, A1, . Location in patent: Page/Page column 12
[12] Patent: US2007/203125, 2007, A1, . Location in patent: Page/Page column 35
[13] Journal of Medicinal Chemistry, 2007, vol. 50, # 17, p. 4003 - 4015
[14] Patent: US6369235, 2002, B1, . Location in patent: Example 46
[15] Patent: WO2016/203401, 2016, A1, . Location in patent: Page/Page column 102
[16] Patent: WO2016/202253, 2016, A1, . Location in patent: Page/Page column 129
[17] Patent: WO2018/104766, 2018, A1, . Location in patent: Page/Page column 102
[18] Patent: US2005/54850, 2005, A1,
[19] Patent: WO2008/56150, 2008, A1, . Location in patent: Page/Page column 180
[20] Journal of Medicinal Chemistry, 1993, vol. 36, # 12, p. 1772 - 1784
[21] Patent: WO2005/70906, 2005, A1, . Location in patent: Page/Page column 21
[22] Patent: US5128356, 1992, A,
[23] Patent: WO2008/42282, 2008, A2, . Location in patent: Page/Page column 131
[24] Patent: US6353010, 2002, B1, . Location in patent: Page column 9
[25] Patent: WO2005/65680, 2005, A1, . Location in patent: Page/Page column 79
[26] Helvetica Chimica Acta, 2009, vol. 92, # 11, p. 2159 - 2172
[27] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 17, p. 5161 - 5164
[28] Patent: WO2008/32027, 2008, A1, . Location in patent: Page/Page column 100
[29] Patent: WO2013/34755, 2013, A1, . Location in patent: Page/Page column 26
[30] Patent: WO2013/34758, 2013, A1, . Location in patent: Page/Page column 19
[31] Patent: EP3287441, 2018, A1, . Location in patent: Paragraph 0490
  • 12
  • [ 116496-81-2 ]
  • [ 16554-45-3 ]
YieldReaction ConditionsOperation in experiment
85% at 60℃; for 2 h; A solution of the nitroacetamide (1.27 mol) in water (1.27 L) was treated with sodium hydroxide (5.07 mol) and the reaction mixture was heated at 60° C. for 2 h.
The precipitated solids were collected by filtration, washed with water, and dried to provide the nitroaniline in 85percent yield as an orange solid.
Reference: [1] Patent: US2007/78147, 2007, A1, . Location in patent: Page/Page column 67
[2] Journal of the Chemical Society, 1926, p. 1319
[3] Letters in Drug Design and Discovery, 2013, vol. 10, # 4, p. 369 - 373
  • 13
  • [ 74-88-4 ]
  • [ 16554-45-3 ]
Reference: [1] Patent: WO2005/68433, 2005, A1, . Location in patent: Page/Page column 38
  • 14
  • [ 16315-07-4 ]
  • [ 16554-45-3 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 2001, vol. 66, # 11, p. 1638 - 1658
[2] Chemische Berichte, 1878, vol. 11, p. 2101
[3] Chem. Zentralbl., 1908, vol. 79, # II, p. 1826
[4] Journal fuer Praktische Chemie (Leipzig), 1930, vol. <2> 127, p. 20,22
  • 15
  • [ 555-03-3 ]
  • [ 16554-45-3 ]
  • [ 96-96-8 ]
Reference: [1] Patent: US5466871, 1995, A,
  • 16
  • [ 7758-89-6 ]
  • [ 555-03-3 ]
  • [ 593-56-6 ]
  • [ 16554-45-3 ]
Reference: [1] Patent: US2004/19058, 2004, A1,
  • 17
  • [ 555-03-3 ]
  • [ 16554-45-3 ]
  • [ 97-52-9 ]
  • [ 96-96-8 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 15, p. 4878 - 4888
[2] Journal of Organic Chemistry, 1996, vol. 61, # 2, p. 442 - 443
[3] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 11, p. 1437 - 1444
  • 18
  • [ 555-03-3 ]
  • [ 16554-45-3 ]
  • [ 97-52-9 ]
Reference: [1] Journal of Organic Chemistry, 1996, vol. 61, # 9, p. 2934 - 2935
  • 19
  • [ 90-04-0 ]
  • [ 16554-45-3 ]
Reference: [1] Letters in Drug Design and Discovery, 2013, vol. 10, # 4, p. 369 - 373
  • 20
  • [ 93-26-5 ]
  • [ 16554-45-3 ]
Reference: [1] Letters in Drug Design and Discovery, 2013, vol. 10, # 4, p. 369 - 373
  • 21
  • [ 64431-77-2 ]
  • [ 16554-45-3 ]
Reference: [1] Australian Journal of Chemistry, 1958, vol. 11, p. 491,497
  • 22
  • [ 38469-85-1 ]
  • [ 16554-45-3 ]
Reference: [1] Australian Journal of Chemistry, 1958, vol. 11, p. 491,497
  • 23
  • [ 5473-00-7 ]
  • [ 16554-45-3 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1930, vol. <2> 127, p. 20,22
  • 24
  • [ 62153-30-4 ]
  • [ 16554-45-3 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1930, vol. <2> 127, p. 20,22
  • 25
  • [ 1002-16-0 ]
  • [ 90-04-0 ]
  • [ 16554-45-3 ]
Reference: [1] Journal of the Chemical Society, 1954, p. 2977
  • 26
  • [ 16315-07-4 ]
  • [ 7664-41-7 ]
  • [ 16554-45-3 ]
Reference: [1] Chemische Berichte, 1878, vol. 11, p. 2101
[2] Chem. Zentralbl., 1908, vol. 79, # II, p. 1826
  • 27
  • [ 116496-81-2 ]
  • [ 15969-08-1 ]
  • [ 16554-45-3 ]
Reference: [1] Journal of the Chemical Society, 1926, p. 1319
  • 28
  • [ 16554-45-3 ]
  • [ 112970-44-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 17, p. 5352 - 5362
[2] Bulletin of the Chemical Society of Japan, 1978, vol. 51, p. 2437 - 2438
  • 29
  • [ 16554-45-3 ]
  • [ 113206-03-4 ]
Reference: [1] Chemistry - A European Journal, 2017, vol. 23, # 42, p. 9996 - 10000
  • 30
  • [ 16554-45-3 ]
  • [ 859877-49-9 ]
Reference: [1] Patent: WO2005/65680, 2005, A1, . Location in patent: Page/Page column 79
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 16554-45-3 ]

Aryls

Chemical Structure| 16554-47-5

[ 16554-47-5 ]

3-Methoxy-2-nitroaniline

Similarity: 0.97

Chemical Structure| 16292-88-9

[ 16292-88-9 ]

3-Methoxy-4-nitroaniline

Similarity: 0.88

Chemical Structure| 1552-17-6

[ 1552-17-6 ]

2-Nitro-5-phenoxyaniline

Similarity: 0.88

Chemical Structure| 1568-70-3

[ 1568-70-3 ]

4-Methoxy-2-nitrophenol

Similarity: 0.88

Chemical Structure| 16292-95-8

[ 16292-95-8 ]

3-Methoxy-4-nitrophenol

Similarity: 0.86

Ethers

Chemical Structure| 16554-47-5

[ 16554-47-5 ]

3-Methoxy-2-nitroaniline

Similarity: 0.97

Chemical Structure| 16292-88-9

[ 16292-88-9 ]

3-Methoxy-4-nitroaniline

Similarity: 0.88

Chemical Structure| 1552-17-6

[ 1552-17-6 ]

2-Nitro-5-phenoxyaniline

Similarity: 0.88

Chemical Structure| 1568-70-3

[ 1568-70-3 ]

4-Methoxy-2-nitrophenol

Similarity: 0.88

Chemical Structure| 16292-95-8

[ 16292-95-8 ]

3-Methoxy-4-nitrophenol

Similarity: 0.86

Amines

Chemical Structure| 16554-47-5

[ 16554-47-5 ]

3-Methoxy-2-nitroaniline

Similarity: 0.97

Chemical Structure| 16292-88-9

[ 16292-88-9 ]

3-Methoxy-4-nitroaniline

Similarity: 0.88

Chemical Structure| 1552-17-6

[ 1552-17-6 ]

2-Nitro-5-phenoxyaniline

Similarity: 0.88

Chemical Structure| 16133-49-6

[ 16133-49-6 ]

5-Methoxy-2-nitrophenylamine

Similarity: 0.81

Chemical Structure| 86771-76-8

[ 86771-76-8 ]

5-Methoxy-4-methyl-2-nitroaniline

Similarity: 0.81

Nitroes

Chemical Structure| 16554-47-5

[ 16554-47-5 ]

3-Methoxy-2-nitroaniline

Similarity: 0.97

Chemical Structure| 16292-88-9

[ 16292-88-9 ]

3-Methoxy-4-nitroaniline

Similarity: 0.88

Chemical Structure| 1552-17-6

[ 1552-17-6 ]

2-Nitro-5-phenoxyaniline

Similarity: 0.88

Chemical Structure| 1568-70-3

[ 1568-70-3 ]

4-Methoxy-2-nitrophenol

Similarity: 0.88

Chemical Structure| 16292-95-8

[ 16292-95-8 ]

3-Methoxy-4-nitrophenol

Similarity: 0.86